
伦敦
He regularly advises on IPOs, direct listings, follow-ons, de-SPACs, reverse mergers and takeovers on UK, U.S. and European stock exchanges, domestic and cross-border public and private M&A deals, venture capital, private and growth equity investments, debt financings, joint ventures, carve-outs, and restructurings, as well as on governance, disclosure, compliance, and strategic advisory matters.
His broad industry experience includes working with clients in the AI and technology, healthcare and life sciences, logistics, retail, media, marketing, financial services, energy and natural resources sectors.
硅谷
Jing’s practice is primarily focused on patent and trade secret litigation. Her experience covers a broad range of technologies including small molecules (salts, polymorphs, formulations, and process patents) and biologic drugs, medical devices, diagnostics, software, and semiconductors. She has worked on Hatch Waxman (ANDA) litigation as well as Biologics Price Competition and Innovation Act (BPCIA) cases defending multi-billion-dollar diabetes and cancer drugs from generic/biosimilar challenges. Her clients have ranged from big pharmaceutical companies, to biotechnology companies, to pre-IPO startups, which uniquely positions her to counsel companies at all stages on portfolio strategy. Jing’s extensive background in biosciences, including years of laboratory research experience, serves her clients well in high-stakes matters before the Patent Trial and Appeal Board, U.S. District Courts, and Federal Circuit. Recently, Jing helped defend the validity of all challenged claims in a salt/polymorph patent in an IPR and was instrumental in developing parallel district court cases for a blockbuster diabetes drug.
Alongside her intellectual property practice, Jing has the privilege of using her Federal Circuit experience to represent veterans pro bono in their appeals to the court.
Prior to joining Orrick, Jing served as a judicial law clerk for Judge Raymond T. Chen at the U.S. Court of Appeals for the Federal Circuit and was an associate at a Vault 100 litigation boutique in Washington, D.C. Before law school, Jing was a Marshall Scholar, and she pursued dual graduate degrees in biosciences and policy studies while conducting public policy research in the U.K. and the United States.
旧金山
Ashley works on single plaintiff and class action cases, defending against discrimination, harassment, retaliation, and wage claims. She also advises employers on employment policies and practices, including compliance with evolving pay transparency laws.
Before becoming a lawyer, Ashley worked in education. She was also a 2020 Pro Bono Orrick Fellow at the Legal Aid Society of San Mateo County, where she practiced eviction defense and special education law.
New York
She begins by gathering an in-depth understanding of her client’s business and goals, and then evaluating the specific issue at hand, so that whether navigating a counseling issue or a complex litigation, she can understand every possible angle and design the best possible solution.
Lisa, who serves as a member of Orrick's Management Committee, regularly litigates a broad range of employment issues in court, administrative agencies, and arbitration. Lisa also helps companies at all stages of development avoid litigation or prevent a single-plaintiff matter from escalating to a class action. She has successfully handled a number of high-stakes arbitrations and internal investigations. In addition, she offers counseling on discrimination, harassment, equal pay, wage and hour issues, disability accommodations, termination and compensation. Lisa regularly advises clients on a variety of employment-related issues, including human resources policies and procedures, offer letters, severance agreements and employee termination.
Prior to joining Orrick, Lisa served as a law clerk to the Hon. Peter Leisure in the United States District Court for the Southern District of New York.
巴黎
She advises French and international groups on all French employment and labor law matters. In particular, on the following matters: company restructurings, merger and acquisition transactions, transfer of activity, collective and individual relationships, hiring and termination of top managers, litigation.
Prior to joining Orrick, Chek-Lhy was an associate for three years in the Employment, Pensions & Benefits department of Freshfields Bruckhaus Deringer, and for four years in the employment team of Linklaters.
Los Angeles
Dr. Lynch's practice centers on representing clients involved in patent litigation and appeals, as well as U.S. Patent and Trademark Office post-grant proceedings. His experience encompasses numerous aspects of the life sciences, including small and large molecule pharmaceuticals, cellular immunotherapies, medical devices, and diagnostics. He has represented biopharmaceutical clients of all sizes, from start-ups to multinational corporations.
Dr. Lynch also counsels clients on pre-litigation strategies relating to their intellectual property, offering advice on matters including patentability, freedom-to-operate, patent prosecution and portfolio management, and licensing.
Dr. Lynch received his J.D. from Loyola Law School, where he graduated #1 in the evening program and top 5% overall while working for another international law firm.
Before law school, Dr. Lynch earned his Ph.D. in cell biology from Columbia University. His dissertation examined the biophysical aspects of cellular motility using advanced microscopy and imaging techniques.
New York
He has long-standing relationships with a great number of utility clients that span many years and complex transactions, advising them on numerous taxable, tax-exempt, and tax-advantaged financings of all types for electric, gas, water and waste water projects and in restructuring and work-outs. These projects include five different nuclear plants, with financing through both the public capital market and through the U.S. Department of Energy.
Carl was one of the leaders in the development of joint action agencies among municipal utilities. He worked on legislation in 20 states to authorize their formation and testified before legislatures and legislative committees in many of these states. He drafted the first modern indenture for cooperative utilities which served as the model that is currently used by almost every generation and transmission cooperative. He worked with TVA in their exit from the Federal Financing Bank program in the 1980’s and in their financings since then. Carl worked with the major generation and transmission cooperatives that have exited the RUS program in structuring and financing their exit.
Carl has also worked with virtually every major investment banking firm and most major domestic and international banks.